Needham & Company Maintains a 'Buy' on Medidata Solutions (MDSO); Fire Flame...$100 Million Dollars
Tweet Send to a FriendGet Alerts MDSO Hot Sheet
Price: $70.41 -2.18%
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Trade MDSO Now!
Needham & Company maintains a 'Buy' on Medidata Solutions (NASDAQ: MDSO) price target of $40.00.
Analyst, Michael Huang, said, "Q2 was rock solid across the board and impressive, highlighted by accelerating non-Rave product growth (100% y/y vs. 60% in Q1),
a mega $100+ million deal (represents application revenue spread over 5 years) with the division of a top-10 pharma, improving competitive win-rates, notable sequential growth in CRO bid activity (up 100% q/q), and record new customer adds (33 vs 17 in Q1 vs. 9 last year), all of which reflects strengthening competitive positioning, favorable demand trends, and a compelling platform strategy."
FY13 EPS estimate raised from $1.49 to $1.54.
For an analyst ratings summary and ratings history on Medidata Solutions click here. For more ratings news on Medidata Solutions click here.
Shares of Medidata Solutions closed at $35.41 yesterday, with a 52 week range of $14.07-$36.50.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Michael Huang, said, "Q2 was rock solid across the board and impressive, highlighted by accelerating non-Rave product growth (100% y/y vs. 60% in Q1),
a mega $100+ million deal (represents application revenue spread over 5 years) with the division of a top-10 pharma, improving competitive win-rates, notable sequential growth in CRO bid activity (up 100% q/q), and record new customer adds (33 vs 17 in Q1 vs. 9 last year), all of which reflects strengthening competitive positioning, favorable demand trends, and a compelling platform strategy."
FY13 EPS estimate raised from $1.49 to $1.54.
For an analyst ratings summary and ratings history on Medidata Solutions click here. For more ratings news on Medidata Solutions click here.
Shares of Medidata Solutions closed at $35.41 yesterday, with a 52 week range of $14.07-$36.50.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UBS Raises PT on Tesoro (TSO)
- UPDATE: Michael Kors (KORS) Under-Appreciated; Canaccord Genuity Starts at Buy
- Goldman Sachs Downgrades Thoratec (THOR) to Neutral
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
Needham & Company
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
